Profound discoveries in physics lie at the heart of medical imaging; techniques in magnetic resonance imaging (MRI) and nuclear medicine have revolutionised diagnostic medicine in the last 40 years. But gaps in our knowledge and capabilities for medical imaging still remain.
We aim to fill these gaps through development and application of new imaging modalities that exploit the high contrast available in tissue using visible and near infrared light. This requires innovation in both instrumentation, to improve sensitivity and penetration depth, and small molecule contrast agents, to provide a “smart” readout on metabolism from the tumour compared to surrounding normal tissue. Our vision is to translate transformative new healthcare technologies into clinical application for improved patient outcomes. We are currently conducting two clinical trials in patients and aiming to establish several more in the coming year.